As I\u2019m sure you know, we\u2019ve given you a long list of pandemic winners here in Trade of the Day<\/em>…<\/p>\n
War Room members started by getting into Clorox before anyone else…<\/p>\n
They were some of the first to move into Teladoc Healthand Zoom…<\/p>\n
Followed by HormelFoods, Flir Systems, AMC Entertainment, Bloomin\u2019 Brands, Bed Bath & Beyond, Pfizer, Ulta Beauty and Tilray.<\/p>\n
The point is…<\/p>\n
Throughout this lockdown pandemic, Karim and I have successfully navigated members through this market volatility with extreme precision – and tremendous profitability.<\/p>\n
And today, with my newest pick, I have every intention of keeping that trend going…<\/p>\n
You see, one new stay-at-home position that I really like right now is Keurig Dr Pepper <\/strong>(NYSE: KDP).<\/p>\n
I\u2019m confident that working from home will now represent a new normal in the U.S.<\/p>\n
And if this is the new reality, then it\u2019s easy to understand why one of the first things every new at-home worker will do is upgrade their coffee maker<\/em>.<\/p>\n
With an 80% share of the popular K-Cup, single-serve coffee market, Keurig Dr Pepper stands to really capitalize.<\/p>\n
In fact, it\u2019s one of the rare companies actually growing<\/em> sales and margins right now.<\/p>\n
Back on April 29, Keurig Dr Pepper beat revenue expectations by 2.5%, reporting sales of $2.6 billion.<\/p>\n
Not only that, but adjusted net earnings of $0.29 per share beat the consensus estimate of $0.27 – outperforming the prior year\u2019s adjusted earnings of $0.25 per share.<\/p>\n
If it\u2019s growing year over year – in this environment – then that\u2019s pretty damn strong.<\/p>\n
Even when coffee shops reopen, the value argument holds up. Instead of spending $4.50 for a coffeehouse latte, making one for yourself at home for pocket change continues to favor Keurig Dr Pepper.<\/p>\n
And coffee is just one piece of its business empire…<\/p>\n
It has Snapple, Mott’s, Hawaiian Punch, Yoo-hoo, Vita Coco, Evian, Canada Dry and 7UP… just to name a few!<\/p>\n
Right now, the most bullish analyst values Keurig Dr Pepper at $33 per share, while the most bearish analyst values it a $25. So the risk versus reward at current levels works in your favor.<\/p>\n
<\/p>\n
Action Plan: <\/strong>For our next work-at-home winner, I like the idea of owning shares of Keurig Dr Pepper at current levels. Oh, throw in a forward annual dividend yield of 2.28%, and that idea only gets stronger.<\/p>\n
Get a position now!<\/p>\n
For more work-at-home winners, join me in The War Room<\/a>!<\/p>\n","protected":false},"excerpt":{"rendered":"